相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study
David M. O'Malley et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation
Zhiwei Fan et al.
ACTA PHARMACEUTICA SINICA B (2022)
Sequential ubiquitination of p53 by TRIM28, RLIM, and MDM2 in lung tumorigenesis
Jun-O Jin et al.
CELL DEATH AND DIFFERENTIATION (2021)
Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1
Dan Zhu et al.
CELL DEATH AND DIFFERENTIATION (2021)
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target
Xiaoqing Wang et al.
CELL (2021)
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells
Simon J. Dovedi et al.
CANCER DISCOVERY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Immunotherapy of gastric cancer: Past, future perspective and challenges
Jun Xie et al.
PATHOLOGY RESEARCH AND PRACTICE (2021)
The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity
Jianhuang Lin et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop
Francesco Marangoni et al.
CELL (2021)
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Hao Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation
Ying Qin et al.
NATURE COMMUNICATIONS (2021)
The E3 ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression by directly targeting Src protein
Lihui Zhu et al.
CELL DEATH AND DIFFERENTIATION (2020)
Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment
Tina Krieger et al.
DIAGNOSTIC PATHOLOGY (2020)
Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells
Yihe Yan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor Efficacy
Jiyong Liang et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Gastric cancer: Epidemiology, risk factors and prevention strategies
Lei Yang et al.
CHINESE JOURNAL OF CANCER RESEARCH (2020)
FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1
Lola Fashoyin-Aje et al.
ONCOLOGIST (2019)
MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
Hui Li et al.
GASTROENTEROLOGY (2019)
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Anand Rotte
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis
Lele Zhu et al.
NATURE CELL BIOLOGY (2019)
TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb
Xiancai Ma et al.
ELIFE (2019)
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
Duaa O. Khair et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance
Jinfang Zhang et al.
NATURE (2018)
TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex
P. Guo et al.
ONCOGENE (2018)
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
Jinfang Zhang et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression
Ka-wing Fong et al.
NATURE COMMUNICATIONS (2018)
Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy
Jung-Mao Hsu et al.
CANCER RESEARCH (2018)
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Riccardo Mezzadra et al.
NATURE (2017)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr et al.
NATURE (2017)
Identification of essential genes for cancer immunotherapy
Shashank J. Patel et al.
NATURE (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
The complexity of TRIM28 contribution to cancer
Patrycja Czerwinska et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras
Tim Wang et al.
CELL (2017)
Deubiquitination and Stabilization of PD-L1 by CSN5
Seung-Oe Lim et al.
CANCER CELL (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
Traver Hart et al.
CELL (2015)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
TRIM28 Represses Transcription of Endogenous Retroviruses in Neural Progenitor Cells
Liana Fasching et al.
CELL REPORTS (2015)
Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
Wei Li et al.
GENOME BIOLOGY (2015)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Ligand-dependent corepressor contributes to transcriptional repression by C2H2 zinc-finger transcription factor ZBRK1 through association with KRAB-associated protein-1
Mario R. Calderon et al.
NUCLEIC ACIDS RESEARCH (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li et al.
GENOME BIOLOGY (2014)
PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing
Alexey V. Ivanov et al.
MOLECULAR CELL (2007)
分享论文
